A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis (Q34024209)

30 July 2017

1 reference

title

A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis (English)

1 reference

30 July 2017

0 references

3

Michael Levy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21932127

12 December 2024

author name string

Christopher Eckstein

series ordinal

1

1 reference

30 July 2017

Shiv Saidha

series ordinal

2

1 reference

30 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21932127

12 December 2024

publication date

20 September 2011

1 reference

full work available at URL

30 July 2017

http://link.springer.com/content/pdf/10.1007/s00415-011-6240-5.pdf

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

http://link.springer.com/article/10.1007/s00415-011-6240-5/fulltext.html

12 December 2024

file format

HyperText Markup Language

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

http://link.springer.com/content/pdf/10.1007/s00415-011-6240-5

12 December 2024

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

12 December 2024

1 reference

30 July 2017

volume

259

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

801-816

1 reference

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Differential diagnosis of suspected multiple sclerosis: a consensus approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Consensus definitions proposed for pediatric multiple sclerosis and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The spectrum of disseminated encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Diagnostic criteria for multiple sclerosis: an historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Acute disseminated encephalomyelitis. Pathogenesis, diagnosis, treatment, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Antibodies as biological markers for pathophysiological processes in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

What is acute disseminated encephalomyelitis (ADEM)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neuromyelitis optica: changing concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The spectrum of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The clinical course of neuromyelitis optica (Devic's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

A population-based study of neuromyelitis optica in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Multiple sclerosis in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neuromyelitis optica and asian phenotype of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

An open label study of the effects of rituximab in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Mitoxantrone induces cell death in peripheral blood leucocytes of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Diagnosis and treatment of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Proposed diagnostic criteria and nosology of acute transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Clinically isolated acute transverse myelitis: prognostic features and incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Nosology of idiopathic transverse myelitis syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Idiopathic inflammatory demyelinating disorders after acute transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Diagnosis and management of acute myelopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Acute transverse myelopathy in adults. A follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

An approach to the diagnosis of acute transverse myelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Sjögren's syndrome: a study of its neurological complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The epidemiology of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Transverse myelitis in patients with antiphospholipid antibodies--the importance of early diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Acute transverse myelopathy complicating systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

MRI and the brain in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Mycophenolate mofetil for induction therapy of lupus nephritis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neurosarcoidosis: Diagnosis and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neurosarcoidosis: a clinical dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Sarcoidosis and its neurological manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Behçet's syndrome and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Acute aseptic meningitis and diffuse myelitis as the presenting features of neurological Behcet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Behçet's disease and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Behçet's syndrome: disease manifestations, management, and advances in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Effect of infliximab in progressive neuro-Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Primary central nervous system vasculitis: analysis of 101 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Central nervous system vasculitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Primary angiitis of the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Vasculitis in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Primary (granulomatous) angiitis of the central nervous system: A clinicopathologic analysis of 15 new cases and a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Idiopathic granulomatous angiitis of the central nervous system. Diagnostic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Primary angiitis of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

OSMS is NMO, but not MS: proven clinically and pathologically

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)

21 January 2018

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

ACUTE TRANSVERSE MYELOPATHY

1 reference

12 December 2020

Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin

1 reference

12 December 2020

Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis

1 reference

12 December 2020

1 reference

12 December 2020

Oligoclonal IgG band patterns in inflammatory demyelinating human and mouse diseases

1 reference

12 December 2020

Acute transverse myelitis with normal brain MRI : long-term risk of MS

1 reference

12 December 2020

Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota

1 reference

12 December 2020

Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients.

1 reference

12 December 2020

Refractory neurosarcoidosis: a dramatic response to infliximab

1 reference

12 December 2020

Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI

1 reference

12 December 2020

Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations

1 reference

12 December 2020

1 reference

12 December 2020

Heterogeneity and continuum of multiple sclerosis in Japanese according to magnetic resonance imaging findings

1 reference

12 December 2020

1 reference

12 December 2020

Idiopathic acute transverse myelitis: application of the recent diagnostic criteria

1 reference

12 December 2020

Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature.

1 reference

12 December 2020

Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

1 reference

12 December 2020

Central nervous system sarcoidosis--diagnosis and management

1 reference

12 December 2020

Clinical management issues in vasculitis. Angiographically defined angiitis of the central nervous system: diagnostic and therapeutic dilemmas

1 reference

12 December 2020

Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide

1 reference

12 December 2020

Early high-dose intravenous methylprednisolone in acute disseminated encephalomyelitis: A successful recovery

1 reference

12 December 2020

The long (-itudinally extensive) and the short of it: transverse myelitis in children

1 reference

12 December 2020

Multiple sclerosis: clinical aspects, acute disseminated encephalomyelitis, neuromyelitis optica and other inflammatory variants

1 reference

12 December 2020

Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms

1 reference

12 December 2020

Seronegative systemic lupus erythematosus

1 reference

12 December 2020

Diagnosing intracranial vasculitis: the roles of MR and angiography

1 reference

12 December 2020

CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography.

1 reference

12 December 2020

Role of MRI in the differentiation of ADEM from MS in children

1 reference

12 December 2020

Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus

1 reference

12 December 2020

Neurological complications in Behçet's syndrome

1 reference

12 December 2020

CNS involvement in neuro-Behçet syndrome: an MR study.

1 reference

12 December 2020

Acute disseminated encephalomyelitis: response to intravenous immunoglobulin

1 reference

12 December 2020

Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children

1 reference

12 December 2020

Acute transverse myelitis in childhood: center-based analysis of 47 cases

1 reference

12 December 2020

Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

1 reference

12 December 2020

Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis

1 reference

12 December 2020

The neurological complications of systemic sarcoidosis.

1 reference

12 December 2020

Diagnosis of sarcoidosis: when is a peek good enough?

1 reference

12 December 2020

Neuromyelitis optica and non organ-specific autoimmunity

1 reference

12 December 2020

Clinical characteristics and course of spinal cord involvement in Behçet's disease

1 reference

12 December 2020

Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years

1 reference

12 December 2020

Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases

1 reference

12 December 2020

1 reference

12 December 2020

Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseases

1 reference

12 December 2020

Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system

1 reference

12 December 2020

European neurological journal

36

3

27

C Eckstein

2011

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

12 December 2024

Transverse myelitis

series ordinal

70

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The Journal of Rheumatology

12 December 2024

90

30

985

G Sanna

2003

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The Journal of Rheumatology

12 December 2024

99

17

89

DT Boumpas

1990

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Cochrane Database of Systematic Reviews

12 December 2024

101

2

CD002265

VF Trevisani

2006

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Annales de médecine interne

12 December 2024

106

152

113

C Chapelon-Abric

2001

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

Current medicine and drugs

12 December 2024

107

7

10

DG James

1967

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

The Journal of Rheumatology

12 December 2024

120

22

662

GF Duna

1995

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

American Journal of Neuroradiology

12 December 2024

132

20

1015

N Kocer

1999

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

American Journal of Neuroradiology

12 December 2024

143

20

75

MG Pomper

1999

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

American Journal of Neuroradiology

12 December 2024

144

15

317

KG Harris

1994

1 reference

https://api.crossref.org/works/10.1007/S00415-011-6240-5

12 December 2024

Identifiers

1 reference

Dimensions Publication ID

30 July 2017

1041233277

0 references

1 reference